FIELD: medicine.
SUBSTANCE: marrow sample is obtained from patient, e.g. by sternal punction, smears are made to define: 1) rate of all erythroid group cells, 2) rate of erythroid group cells carrying erythropoietin receptors on their surface. If both rates are equal or differ not more than by 2.5%, then conclusion on susceptibility of this patient to recombinant human erythropoietin therapy is drawn, and if the rates differ more than by 2.5%, conclusion on in susceptibility of this patient to recombinant human erythropoietin therapy of chronic disease anemia.
EFFECT: high sensitivity and specificity of method.
1 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| MEANS FOR CORRECTION OF VIOLATIONS IN HEMOGENESIS ERYTHROID LINEAGE CAUSED BY CYSTOSTATIC IMPACT | 2016 |
|
RU2634572C1 |
| METHOD FOR DIFFERENTIAL DIAGNOSIS OF ANEMIA SYNDROME IN TYPE 1 AND TYPE 2 DIABETES MELLITUS | 2021 |
|
RU2770744C1 |
| METHOD FOR SIMULATING CHRONIC CYTOSTATIC MYELOSUPPRESSION | 2012 |
|
RU2488890C1 |
| METHOD FOR PREDICTION OF CLINICAL EFFECTIVENESS OF PATIENTS WITH NON-HODGKIN LYMPHOMAS WITH BONE MARROW INVOLVEMENT | 2012 |
|
RU2526796C2 |
| METHOD FOR CORRECTION OF ANEMIA IN ERYTHROCYTES TRANSFUSION DEPENDENT PATIENTS WITH BETA-THALASSEMIA | 2023 |
|
RU2820878C1 |
| METHOD FOR DIFFERENTIAL DIAGNOSIS OF ANAEMIA OF CHRONIC DISEASES AND IRON DEFICIENCY ANAEMIA IN PATIENTS WITH INFLAMMATORY JOINT DISEASES | 2024 |
|
RU2825523C1 |
| PREDICTION METHOD FOR LYMPHOMA CLINICAL COURSE SEVERITY AND TREATMENT EFFICIENCY | 2007 |
|
RU2345367C1 |
| MEDICATION PREVENTING DEVELOPMENT OF DEPRESSION OF HEMATOPOIESIS ERYTHROID LINEAGE IN CASE OF CYTOSTATIC MYELO DEPRESSIONS | 2007 |
|
RU2351333C1 |
| HAEMOSTIMULATING AGENT | 2013 |
|
RU2535021C1 |
| METHOD FOR PREDICTING ANEMIA IN CASE OF DIABETIC ANGIOPATHIES (DA) | 2001 |
|
RU2216274C2 |
